Role of imaging in assessment of treatment responses and complications in patients undergoing new lung cancer therapies - Amsterdam 2025

A new era of endobronchial ultrasound and imaging in staging and treatment of lung cancer from a global perspective

Chair(s): Walter De Wever, Amanda Dandanell Juul, Marjolein A. Heuvelmans

Session type: Symposium

Role of imaging in assessment of treatment responses and complications in patients undergoing new lung cancer therapies

Katarzyna Blasinska

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

What are new needs in clinical practice for lung cancer diagnosis and staging in light of the updated 9th TNM edition for classification of lung cancer?

António Alexandre Pinto Bugalho De Almeida

Replay

Slides

New requirements in staging and restaging of mediastinum and lung cancer introduced by guided radiotherapy and neoadjuvant chemoimmunotherapy

Ales Rozman

Replay

Slides

Role of imaging in assessment of treatment responses and complications in patients undergoing new lung cancer therapies

Katarzyna Blasinska

Replay

Slides

Obstacles, limitations and challenges in lung cancer diagnosis and management in low-to-middle-income countries: differences and similarities

Sabita Jiwnani

Replay

Slides

Discussion and Q&A

Replay

Session aims

to present significant changes in use of endobronchial ultrasound (EBUS) to clinical practice; to discuss new expectations from EBUS procedures that should enable not only more precise N1 staging but also tissue sampling for biomarker analysis; to discuss responses to new lung cancer treatment and possible complications in imaging studies; to point out differences in diagnosis and treatment of lung cancer in low- and middle-income countries.

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}